SCHEMBL29795658

SCHEMBL29795658

O=C(NCCc1ccccc1)n1cnc2cnccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ASAH1 Q13510 9/20 0.63
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
NPC1 O15118 1/20 0.48
NAMPT P43490 1/20 0.46
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
BCHE P06276 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
KDM6B O15054 1/20 0.44
KDM4C Q9H3R0 1/20 0.44
PRMT3 O60678 1/20 0.44
TRPV1 Q8NER1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29795596 0.90 ASAH1 (0.63) ASAH1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL29795449 0.86 ASAH1 (0.83) ASAH1RAB9ASMN1; SMN2NPC1ALDH1A1
SCHEMBL23122842 0.86 ASAH1 (0.83) ASAH1RAB9ASMN1; SMN2NPC1ALDH1A1
SCHEMBL29795498 0.84 ASAH1 (0.65) ASAH1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL28794578 0.84 ASAH1 (0.65) ASAH1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL23124361 0.82 ASAH1 (0.54) ASAH1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL23123367 0.80 ASAH1 (0.54) ASAH1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL23122802 0.80 ASAH1 (0.56) ASAH1RAB9AALDH1A1CYP1A2BCHE
SCHEMBL28945618 0.80 ASAH1 (0.62) ASAH1RAB9ANPC1ALDH1A1CYP1A2
SCHEMBL29795660 0.80 ASAH1 (0.62) ASAH1RAB9ANPC1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4031532-A1 SUBSTITUTED BENZIMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS Bial-R&D Investments, S.A. (PT) 2022-07-27 EP disclosed